This has two meanings:
(1) European Medicines Evaluation Agency, a coordinating organization for the European national agencies that evaluate medicinal products for human and veterinary use. It was created by the European Commission in 1993 to administer a centralized approval procedure, which is mandatory for biotechnology and optional for other high-technology and innovative pharmaceutical products, and also to arbitrate disputes under decentralized procedures in order to achieve mutual recognition of EU member state’s national approvals of medicines;
(2) in marketing and management terms, an acronym for Europe, Middle East, and Africa or alternately Asia.